Provided by Tiger Trade Technology Pte. Ltd.

Novavax

7.32
-0.1200-1.61%
Post-market: 7.30-0.0169-0.23%19:59 EDT
Volume:3.41M
Turnover:24.90M
Market Cap:1.20B
PE:-12.66
High:7.49
Open:7.44
Low:7.22
Close:7.44
52wk High:11.97
52wk Low:6.20
Shares:164.43M
Float Shares:141.00M
Volume Ratio:1.16
T/O Rate:2.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5784
EPS(LYR):2.58
ROE:-898.20%
ROA:1.99%
PB:-8.31
PE(LYR):2.84

Loading ...

Stock Track | Novavax Plummets 5.04% Intraday on FDA Vaccine Composition Uncertainty

Stock Track
·
May 28

Sanofi Says Manufacturing Xfg Protein Nuvaxovid Vaccine as Its Single Global Covid-19 Product for the 2026-27 Season: Briefing Docs

THOMSON REUTERS
·
May 28

FDA advisers to weigh composition of COVID vaccines for 2026-2027

Reuters
·
May 28

Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 28

Novavax Inc. Stock Rallies 13.6%, Outperforms Peers

Dow Jones
·
May 27

Stock Track | Novavax Soars 12.54% as FDA Considers XFG-Targeted COVID Vaccine Update

Stock Track
·
May 26

US FDA advisers to weigh updating 2026-27 COVID vaccines to target XFG variant

Reuters
·
May 26

The Bull Case For Novavax (NVAX) Could Change Following Shah Capital’s Activist Governance Challenge - Learn Why

Simply Wall St.
·
May 25

Assessing Novavax (NVAX) Valuation As Shah Capital Challenges Leadership And Sanofi Partnership

Simply Wall St.
·
May 23

Novavax Updates Pediatric COVID-19 Vaccine Trial: What Investors Should Watch

TIPRANKS
·
May 23

Novavax Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
May 22

Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 21

Novavax Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
May 19

Are Novavax’s (NVAX) Activist Pressure and Partnership Pivot Quietly Rewriting Its Investment Narrative?

Simply Wall St.
·
May 16

BRIEF-Coatue Management Cuts Share Stake in Tesla by 96.4%, SEC filing shows

Reuters
·
May 16

Shah Capital Management: Believe 10-20 Mln Novavax Shares Must Be Bought in Q2 to Show Confidence in Its Science & Strategy & Reducing Past Dilution

THOMSON REUTERS
·
May 15

Shah Capital Management: Will Vote ‘No' Across Five Proposals on Novavax's June 18 Ballot - SEC Filing

THOMSON REUTERS
·
May 15

Shah Capital Management: Believe Novavax Must Be Profitable in 2026 Through Further Cuts in Spending Including SG&a, R&D –AI Centric Operations

THOMSON REUTERS
·
May 15

Shah Capital Management - on May 14, 2026, Shah Capital Management Sent Presentation to Novavax's Board

THOMSON REUTERS
·
May 15

Shah Capital Management: Beheve Covid/Flu Combo Phase 3 Either Through Sanofi or Novavax's Own (Creative Partnership) Must Start Immediately

THOMSON REUTERS
·
May 15